BORA PHARMACEUTICALS LTD (6472) — Financial Flexibility Index
BORA PHARMACEUTICALS LTD (6472) has a Financial Flexibility Index of 0.03x as of March 2026. Free cash flow of NT$779.54 Million (operating CF NT$568.46 Million minus capex NT$211.08 Million) represents 0% of total liabilities (NT$28.70 Billion). Check BORA PHARMACEUTICALS LTD investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
BORA PHARMACEUTICALS LTD Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for BORA PHARMACEUTICALS LTD across 7 annual periods. For the full cash flow conversion analysis, see 6472 cash flow metrics.
Annual Financial Flexibility Index for BORA PHARMACEUTICALS LTD (2019–2025)
Year-by-year free cash flow to debt coverage for BORA PHARMACEUTICALS LTD. Explore 6472 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.19x | NT$5.17 Billion | NT$4.24 Billion | NT$27.24 Billion | ▲ +248.1% |
| 2024 | 0.05x | NT$1.67 Billion | NT$980.81 Million | NT$30.59 Billion | ▼ -88.0% |
| 2023 | 0.45x | NT$6.04 Billion | NT$4.61 Billion | NT$13.29 Billion | ▲ +262.7% |
| 2022 | 0.13x | NT$2.21 Billion | NT$2.01 Billion | NT$17.62 Billion | ▼ -66.9% |
| 2021 | 0.38x | NT$1.60 Billion | NT$1.24 Billion | NT$4.22 Billion | ▲ +421.8% |
| 2020 | 0.07x | NT$329.88 Million | NT$177.79 Million | NT$4.54 Billion | ▼ -86.5% |
| 2019 | 0.54x | NT$929.10 Million | NT$231.77 Million | NT$1.73 Billion | — |